Searle & Co. Heron Therapeutics, Inc. Put Options Transaction History
Searle & Co.
- $390 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HRTX
# of Institutions
168Shares Held
119MCall Options Held
151KPut Options Held
103K-
Rubric Capital Management LP New York, NY26.7MShares$79.3 Million2.52% of portfolio
-
Orbimed Advisors LLC San Diego, CA10.1MShares$30 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$24.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$21.6 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$20.8 Million21.7% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $353M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...